Table 2 Intraoperative and postoperative data and complications
CTP group (n = 23) | SP group (n = 18) | P value | |
|---|---|---|---|
Operative time (min) | 109.63 ± 21.05 | 143.20 ± 29.94 | < 0.001 |
EBL (mL) | 178.26 ± 30.70 | 347.78 ± 53.53 | < 0.001 |
Post-op hospital stays (days) | 3.00 ± 1.33 | 3.89 ± 2.30 | 0.112 |
Catheterization time (days) | 10.96 ± 2.01 | 11.89 ± 2.00 | 0.147 |
Positive surgical margin (n, %) | 8 (34.8) | 6 (33.3) | 0.923 |
Pathological T stage (n, %) | 0.875 | ||
T2a | 3 (13.0) | 2 (11.1) | |
T2b | 1 (4.3) | 2 (11.1) | |
T2c | 8 (34.8) | 6 (33.3) | |
T3a | 11 (47.9) | 8 (44.5) | |
Post-op complications (n, %) | |||
Clavien I–II | 3 (13.0) | 2 (11.1) | 0.851 |
Clavien III–V | 0 (0) | 0 (0) | 0 (0) |
3 months post-op detectable PSA (n, %) | 1 (4.3) | 0 (0) | 0.370 |
6 months recovery rate of urinary continence (n, %) | 20 (86.9) | 14 (77.7) | 0.438 |
Cost of robotic surgery (¥) | 40,575.49 ± 1486.83 | 34,737.88 ± 1762.79 | <0.001 |